Healthcare services company McKesson has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures (Core Ventures) for about $2.49 billion.
Core Ventures, a business and administrative services organization, was established by Florida Cancer Specialists and Research Institute, a physician-owned community oncology practice. FCS physicians will continue to retain a minority interest in Core Ventures.
